Management of Acute Sickle Cell Disease Pain

Pediatr Rev. 2024 Jan 1;45(1):26-38. doi: 10.1542/pir.2022-005631.

Abstract

Pain is a common complication of sickle cell disease. Sickle cell pain can often be effectively managed by pediatricians in outpatient and hospital settings. Acute pain management should be initiated quickly. Patients need to be evaluated for sickle cell complications and other causes of pain. Nonsteroidal anti-inflammatory drugs and opioids are the mainstay of pain treatment, but additional therapies include hydration, local pain control, muscle relaxants, and nonpharmacologic approaches. Healthy lifestyle habits and good behavioral and mental health are important for preventing and coping with sickle cell disease pain. Disease-modifying therapies, such as hydroxyurea, can help prevent sickle hemoglobin polymerization and acute pain episodes. Because sickle cell disease largely affects people who are racialized minorities in the United States, health-care providers need to be aware of how their own personal biases may affect care of these patients.

MeSH terms

  • Acute Pain* / complications
  • Acute Pain* / therapy
  • Analgesics, Opioid / therapeutic use
  • Anemia, Sickle Cell* / complications
  • Anemia, Sickle Cell* / therapy
  • Humans
  • Hydroxyurea / therapeutic use
  • Pain Management
  • United States

Substances

  • Hydroxyurea
  • Analgesics, Opioid